St John's Medical College

Key areas of Research

  • Feasibility of the investigators and the institution done in several clinical trials in the treatment of various cancers including Breast cancer and lung cancer, awaiting the IERB dates.
  • Title: “An Open – Label Multicentric Randomized, Two Treatment, Two Period Two Sequence Cross – over, single Dose, Bioequivalence Study of Test Melphalan 50mg powder for solution for infusion Manufactured by Sindan – Pharma SRL, Romania for Actavis  Group PTC ehf Iceland with Reference Alkeran ( Melphalan) 50mg Powder and Solvent for Solution for Infusion Manufactured by Aspen Pharma, Ireland in Patients with Advanced Ovarian Cancer”